{"retracted":false,"update":{"timestamp":1401235200000,"doi":"10.1007/s11888-014-0228-3","type":"correction"},"doi":"10.1007/s11888-013-0187-0","journal":"Current Colorectal Cancer Reports","publisher":"Springer Nature","title":"Erratum to: Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same?"}
